PHIL.MI MIL
Philogen S.p.A.
1W: -1.8%
1M: -4.1%
3M: -9.8%
YTD: +3.7%
1Y: -5.9%
3Y: +34.5%
€22.20 ($24.84)
-0.10 (-0.45%)
Weekly Expected Move ±3.5%
€21
€21
€22
€23
€24
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#1
of 4
Biotechnology
Technical Signal Map
0 Bullish
1 Neutral
3 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| PHIL.MI Philogen S.p.A. | $640M | 4.0 | 2.4 | 1178.3 | -482.0 | 19.7 | 6 | BEARISH | -5.9 |
| HLX.MI Helyx Industries S.p.A. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ARBS.MI Arterra Bioscience | $20M | 11.6 | 28.7 | 11.0 | 44.3 | 46.3 | 6 | BEARISH | 15.5 |
| NWRN.SW Newron Pharmaceuticals S.p.A. | $420M | -6.0 | 19.5 | 414.9 | -513.4 | 346.9 | 6 | BEARISH | -5.5 |
| PHIL.MI Philogen S.p.A. | $640M | 4.0 | 2.4 | 1178.3 | -482.0 | 19.7 | 6 | BEARISH | -5.9 |
| HLX.MI Helyx Industries S.p.A. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ARBS.MI Arterra Bioscience | $20M | 11.6 | 28.7 | 11.0 | 44.3 | 46.3 | 6 | BEARISH | 15.5 |
| NWRN.SW Newron Pharmaceuticals S.p.A. | $420M | -6.0 | 19.5 | 414.9 | -513.4 | 346.9 | 6 | BEARISH | -5.5 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
PHIL.MI vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F